PRNewsWire
23 Oct 2025, 14:00 UTC · 51w ago
Impact · against what's priced in
CarMax faces significant downward pressure following a substantial Q2 FY2026 earnings and sales miss, compounded by a new securities fraud investigation. HCA Healthcare and York Space Systems are also facing legal risks via separate investigations and lawsuits mentioned in the release.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish
CarMax reported Q2 FY2026 EPS of $0.64 and sales of $6.6 billion, significantly missing consensus estimates of $1.03 EPS and $7 billion in sales.
More negative than 99% of claims this week
Pomerantz LLP is investigating CarMax and its officers for potential securities fraud or unlawful business practices.
Continue reading
5 related stories
CarMax missed Q2 FY2026 EPS estimates by $0.39 and sales by $0.4 billion, triggering a 20% stock price drop and a subsequent investigation by Pomerantz LLP into potential securities fraud.
Read from the article alone
No priced-in read yet
York Space Systems is the subject of a class action lawsuit with upcoming deadlines for investors to join.
Read from the article alone
No priced-in read yet
Pomerantz LLP is investigating claims on behalf of investors regarding potential misconduct at HCA Healthcare.
Read from the article alone
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 90% of claims this week
CarMax plans to reduce selling, general and administrative (SG&A) spending by $150 million over the next 18 months.
So whatCost-cutting measures are a positive step toward margin preservation during a challenging period, though they acknowledge operational headwinds.
More positive than 56% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a securities fraud investigation following a significant earnings miss and a 20% drop in stock price.
More negative than 85% of ticker scores this week
The law firm is investigating claims on behalf of investors regarding potential misconduct.
More negative than 85% of ticker scores this week
The company is the subject of a class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Business Wire
5h ago
—
No price for YSS right now — the quote feed didn't answer.
YSS chart →+4.1%
Price is moving against the score
$459.40 vs $441.19 close before publication (Oct 22) · not market-adjusted
HCA chart →+17.4%
Price is moving against the score
$51.49 vs $43.86 close before publication (Oct 22) · not market-adjusted
KMX chart →
